On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
In 2018, PMI BioPharma Solutions was established in Nashville to offer a full range of research and development…
In 2018, the Native BioData Consortium was founded as a 501(c)(3) nonprofit research institute led by Indigenous scientists…
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
On Dec. 6, 2017, Costco Founder Jeffrey and Susan Brotman and Pam and Dan Baty announced a $50…
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 29, 2017, scientists at The Scripps Research Institute (TSRI) announced they had designed a bacterium with…
On Nov. 28, 2017, surgeons at University of Washinton Medicine in Seattle announced they had performed the first…
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
On. Nov. 13, 2017, research by Dr. Patrick McGovern, Director of the Biomolecular Archaeology Laboratory at the University…
On Nov. 10, 2017, the Wyss Medical Foundation pledged $2 million to support James P. Stannard as the…
On Nov. 9, 2017, the FDA licensed Heplisav-B, the new hepatitis B vaccine, to Berkeley-based Dynavax Technologies for…
On Nov. 9, 2017, UNMC announced that Jingwei Xie, Ph.D, a biomedical engineer, had been awarded a four-year,…
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
On Dec. 1, 2017, Quest Diagnostics announced it acquired Cleveland HeartLab, a leader in innovative diagnostic services for…
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…
On Oct. 11, 2017, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
On Oct. 11, 2017, the Paul G. Allen Frontiers Group announced the creation of two new Allen Discovery…
On Oct. 6, 2017, UC Berkeley researchers announced they had developed reimagined fMRI techniques and instruments to boost…
On Oct. 2, 2017, The Nobel Assembly announced that Michael Rosbash, a HHMI investigator, Jeffrey Hall of Brandeis…